SA Flag
Sign In Sign Up

Reduce Claims & Improve Member Health

Zinacare partners with medical aid providers to enable frequent at-home lab testing for members—improving early detection, reducing preventable claims, and driving better long-term outcomes.

Smarter Benefits, Healthier Members: Partner with Zinacare

Reduce long-term healthcare costs while enhancing your members’ wellbeing. Zinacare’s at-home lab testing empowers earlier detection, ongoing care engagement, and clinically reliable data—at a fraction of the traditional cost.

Better Member Outcomes

Promote proactive health monitoring with frequent, accessible testing.

Cost Containment

Identify and manage health risks early to reduce expensive claims.

Enhanced Engagement

Drive member participation with easy-to-use, in-home lab solutions.

Clinical-Grade Data

Get actionable lab results to inform care coordination and reporting.

Piloting the Future of Preventative Care

Zinacare has partnered with select South African medical aid providers to explore the impact of at-home lab testing on member health outcomes and healthcare costs. These pilot programs aim to close screening gaps, increase testing frequency, and detect risks earlier—ultimately reducing claims and improving care.

Members receive easy-to-use, at-home kits for conditions like diabetes, cholesterol, STIs, and more. Once samples are returned to our accredited labs, results are shared securely with both members and care teams, encouraging follow-up and timely interventions.

Pilots are still underway, and we welcome forward-thinking medical aid schemes looking to innovate, boost engagement, and offer smarter preventative benefits. Let’s build a healthier future together.

Request Demo
Medical Aid Case Study

Unlock Better Health Outcomes for Your Members

Zinacare enables medical aid schemes to drive preventative care through accessible, lab-accurate at-home testing. Reduce claims, improve chronic condition management, and empower members with seamless diagnostics from the comfort of home.